©2026 Bryn Mawr Communications, LLC.
All Rights Reserved

Terms and Conditions • Privacy Policy

Eyewire News: The Podcast
Eyewire Podcast Logo Outlined
Eyewire News: The Podcast

01.08.25

Glaukos Submits NDA for Epi-On CLX Candidate

Glaukos submits a new drug application to the FDA for its next-generation cross-linking therapy; Regeneron releases phase 3 results for Eylea HD for RVO; and Regeneron acquires a clinical stage biotech making ocular delivery technology for retinal disorders. Learn more about your ad choices. Visit megaphone.fm/adchoices

View full description +

MORE EPISODES

01.07.26

Staar Terminates Merger with Alcon

12.31.25

2025 Year in Review - Part 2

12.24.25

2025 Year in Review - Part 1

12.17.25

Update on Reproxalap PDUFA Timing

12.10.25

New Glaucoma Technologies Advance in Clinical Development

12.03.25

Eylea HD Approved for RVO and Extended Dosing

11.26.25

Leaders Discuss Emerging Technologies in Glaucoma

11.18.25

Live Coverage of B+L Investor Day

Show More

Anterior 3D Cataract Cornea General Glaucoma Optometry Pediatric Refractive/LVC Residents & Fellows Retina Retina 3D
close-x